Related Experiment Video

Updated: Aug 13, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.5K

Tumefactive multiple sclerosis presents with painless progressive hemiparesis and aphasia

Michael Guger1, Gerhard Ransmayr2, Michael Sonnberger3

  • 1Department of Neurology, Pyhrn-Eisenwurzen Hospital Steyr, Steyr, Austria; Medical Faculty, Johannes Kepler University Linz, Linz, Austria.

Lancet (London, England)
|January 21, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Neuronavigation-guided Repetitive Transcranial Magnetic Stimulation for Aphasia
08:48

Neuronavigation-guided Repetitive Transcranial Magnetic Stimulation for Aphasia

Published on: May 6, 2016

12.3K
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.8K

Related Experiment Videos

Last Updated: Aug 13, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.5K
Neuronavigation-guided Repetitive Transcranial Magnetic Stimulation for Aphasia
08:48

Neuronavigation-guided Repetitive Transcranial Magnetic Stimulation for Aphasia

Published on: May 6, 2016

12.3K
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.8K

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

24
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
24
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

644
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
644

Articles linked to this work by shared authors, journal, and citation graph.

Investigating the association between grey matter hypoperfusion and atrophy in multiple sclerosis using arterial spin labelling.

Brain communications·2026

Current practices in delirium prevention and treatment after acute stroke: results of a multicentre survey.

Therapeutic advances in neurological disorders·2026

Stable reduction of upper cervical spinal cord area in cervical dystonia.

Parkinsonism & related disorders·2026

Reluctance to Video Recording in Functional Movement Disorders: A Cross-Sectional Study.

Brain and behavior·2026

Sex differences in aetiology of intracerebral haemorrhage and associated small vessel disease patterns.

European stroke journal·2026

HERMES-24 score for outcome prediction in large vessel occlusion stroke: Real-world data from the Austrian stroke network.

International journal of stroke : official journal of the International Stroke Society·2026

Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.

Lancet (London, England)·2026

Robotic-arm-assisted versus conventional total knee replacement (RACER-Knee): a pragmatic, multicentre, participant-masked and assessor-masked, superiority, randomised controlled trial.

Lancet (London, England)·2026

Risk of transmission of amyloid β pathology via transfused blood products.

Lancet (London, England)·2026

Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial.

Lancet (London, England)·2026

The hidden burden of depressive symptoms on functional autonomy in cognitive decline.

Neurodegenerative disease management·2026

Unraveling the protective effect of weekend catch-up sleep on overactive bladder risk.

Annals of medicine·2026

New pharmacological and biotechnological approaches for the treatment of neurotrophic keratopathy: From growth factors to gene therapy.

Indian journal of ophthalmology·2026

IL-12 Signaling Promotes Podocyte Senescence in Lupus Nephritis.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Neurological disease progression in adults with ataxia telangiectasia: a longitudinal study.

Brain : a journal of neurology·2026

Diabetes and neurodegeneration in cognitively unimpaired older adults: implications for cognition.

Brain : a journal of neurology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us